Diagnostics pre-clinical services program - IDIQ - resourcepath

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N93023D00018
Awardee
Awarding agency
Task orders
2 $749,697 obligated

Award facts

Opportunity
Combined order value
  • $749,697 Current, with exercised options
  • $831,984 Potential, with all options
Last date to order 48% complete
IDV ceiling 6% used
$12,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 12 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award indefinite-delivery contract to Resourcepath, LLC with a ceiling of $12 million on June 20, 2023. Resourcepath is a Women-Owned Small Business. The contract is not set-aside. Place of performance is Sterling, Virginia through June 19, 2030.

The IDIQ procures diagnostic pre-clinical services to support the development of in vitro diagnostic products for the detection, identification, and characterization of human infectious agents. Scope includes product development processes and documentation, recombinant proteins and monoclonal antibodies, biochemical reagents, clinical specimens and bacterial isolates, next-generation sequencing, immunoassays and nucleic acid amplification assays, and pre-pilot and pilot-scale GMP manufacturing services. Services fall under NAICS 541711 (Research and Development in the Physical, Engineering, and Life Sciences) and PSC D399 (Medical and Surgical Instruments and Supplies).

Period of performance runs through June 19, 2030. Two delivery orders have been issued under this IDIQ: a $3,500 firm fixed price order for pre-clinical diagnostic services program support (awarded June 20, 2023, completing June 19, 2030), and an $828,484 firm fixed price delivery order to improve analytical assay performance of the Fluxergy SARS-CoV-2 PCR assay (awarded June 20, 2023, completing March 12, 2025). Both delivery orders are performed in Sterling, Virginia.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N93023D00018?

75N93023D00018 was awarded to Resourcepath, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 20, 2023.

How much is contract 75N93023D00018 worth?

Orders under 75N93023D00018 have obligated $749,697. Their combined potential value, with all options, is $831,984. 75N93023D00018's own ceiling is $12,000,000.

How many orders have been placed under contract 75N93023D00018?

2 orders have been placed under 75N93023D00018, the latest on June 20, 2023.

Who can order from contract 75N93023D00018?

75N93023D00018 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N93023D00018 competed?

The extent of competition for 75N93023D00018 was full and open competition. The government received 12 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV